Program in Health Economics and Outcomes Research Methodologies (PHEnOM)

The Program in Health Economics and Outcomes Methodology (PHEnOM) at The CHOICE Institute is a joint program with the Department of Health Service in the School of Public Health at the University of Washington, Seattle. The program aims to facilitate intellectual activities within the departments in the fields of health economics, econometrics and methodology development in outcomes research and to engage researchers in allied fields around the city of Seattle. Key competencies of PHEnOM affiliates include health econometrics, health policy evaluation, applications in health capital, aging and disability, organization of health care, simulations methods, and comparative and cost effectiveness analysis.

PHEnOM Seminar Series

PHEnOM hosts a weekly seminar series during the academic year. All students, faculty and other researchers interested in this area will be encouraged to attend the seminar series. The 1.5 hour seminar will be held in the Rm H371 at the Health Sciences Building (directions) every Wednesday 3 – 4:30pm unless otherwise noted.
To present at the PHEnOM seminar series, contact Anirban Basu at basua@uw.edu or Douglas Barthold at barthold@uw.edu

Dates Speaker Title
Sep 26 NO SEMINAR AHEW Week
Oct 3 Melissa Knox Universal health care and chronic disease management: Exploring the role of health care reform in diagnosis and treatment for diabetes-related complications in Mexico
Oct 10 Douglas Barthold The effects of state level pharmacist regulations on generic substitution of subscription drugs
Oct 17 Joelle Abramowitz, University of Michigan Access to Assisted Reproductive Technology and Maternal Mortality
Oct 24 Jessica Jones-Smith Increased economic resources and childhood obesity: A quasi-experimental study
Oct 31 NO SEMINAR HALLOWEEN
Nov 7 Sang-Eun Choi, Korea University Current pharmaceutical policy and HTA from the Korean National Health Insurance perspective
Nov 14 Elizabeth Brouwer Exploring the shift to value-based formularies in private health insurance 2010-2013 and modeling their potential impact in the future
Nov 21 NO SEMINAR THANKSGIVING
Nov 28 Carrie Bennette, Flatiron Health Building external control arms for clinical trials using real-world data: opportunities and challenges
Dec 5 Anirban Basu Does current practice of evidence-based medicine breeds disparities?

Subscribe to the phenom-info email list.

Seminar Archives

2018201720162015201420132012

January 17, 2018
Jevay Grooms
Race, Gender, and Opioid Treatment Admissions: The Effect of PDMPs on the Most Afflicted

January 24, 2018
Bianca Frogner
Commuting Patterns of Healthcare Workers

January 31, 2018
Carol Levin
Voluntary Male Medical Circumcision (VMMC)  costs and unit costs from the Global Health Cost Consortium

February 7, 2018
Gang Luo
Identifying Future High-Cost Patients for Care Management

February 14, 2018
Liisa Laine
Quality and Competition between Public and Private Firms

February 21, 2018
Shan Liu
Optimizing dynamic decision-making: models and insights for chronic disease care

February 28, 2018
Meng Li
The real option value of life and innovation

March 7, 2018
Mark Bounthavong
Providers’ knowledge, attitude, and satisfaction with Academic Detailing in Opioid Overdose Education and Naloxone Distribution

March 28, 2018
Domenico Depalo, Bank of Italy
Explaining the relation between pills and cholesterol through the marginal patient

April 4, 2018
Yates Coley, KPWHRI
Effectively communicating your research results using statistical graphics

April 11, 2018
Liisa Laine
Market-level effects of a Large-Scale School Choice Reform

April 18, 2018
Amber Sabbatini
Hospital observation stays: implications for costs and quality

April 25, 2018
Ragan Hart
Using Real-World Pharmacogenetic Knowledge Resources to Guide Clinical Decision-Making

May 2, 2018
Peter Neumann
Special Presentation ( jointly sponsored by HICOR, Fred Hutch)

May 9, 2018
Guido Cataife, IMPAQ
Generalization of the Difference-in-Differences Model for Applied Research

May 16, 2018
Alice Ellyson
The Economic and Clinical Impact of Washington state’s Oral Chemotherapy Parity Law

March 28, 2018
Domenico Depalo, Bank of Italy
Explaining the relation between pills and cholesterol through the marginal patient

April 4, 2018
Yates Coley, KPWHRI
Effectively communicating your research results using statistical graphics

April 11, 2018
Liisa Laine
Market-level effects of a Large-Scale School Choice Reform

April 18, 2018
Amber Sabbatini
Hospital observation stays: implications for costs and quality

April 25, 2018
Ragan Hart
Using Real-World Pharmacogenetic Knowledge Resources to Guide Clinical Decision-Making

May 2, 2018
Peter Neumann
Special Presentation ( jointly sponsored by HICOR, Fred Hutch)

May 9, 2018
Guido Cataife, IMPAQ
Generalization of the Difference-in-Differences Model for Applied Research

May 16, 2018
Alice Ellyson
The Economic and Clinical Impact of Washington state’s Oral Chemotherapy Parity Law

1/12/2017
Amy Cizik, University of Washington
Developing Health State Vignettes for Estimating Health State Utility Values in Soft Tissue Sarcoma: Methods, Lessons, and Implications

1/19/2017
Jane Lange, Group Health Research Institute
A Framework for Treatment Decision Making at Prostate Cancer Recurrence

1/26/2017
Sungchul Park, University of Washington
Towards assessing individual-level prediction accuracy for healthcare expenditures: comparing alternative estimators for risk adjustment of payments to health plans

2/2/2017
Alex Woershing, University of Washington
A Proposal for Evaluating a Campaign to Promote Use of a Price Estimator Web Tool for Clinical Services

2/09/2017
Bianca Frogner, University of Washington
Does Medicare Managed Care Affect Diabetic Patient Cost, Use and Quality Associated with Different Medical Labor Inputs

2/16/2017
M. Ragan Hart, University of Washington
Projected Cost-Effectiveness of an Array-Based Multi-Gene Pharmacogenetic (PGx) Testing Panel in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention

2/23/2017
Anobel Odisho, University of Washington
Beyond Classical Risk Adjustment: Socioeconomic Status and Hospital Performance in Urologic Oncology

3/2/2017
Nicholas Papageorge, Johns Hopkins University
Innovation and Diffusion of Medical Treatment

3/09/2017
Joan Teno, University of Washington
Transparency and Accountability for Community Based Programs for High Cost, High Need Patients

3/30/2017
Lindsay White, University of Washington
Current costs of Alzheimer’s Care

4/06/2017
Ankur Pandya, Harvard University
The Arranged Marriage of Pay-for-Performance and Cost-Effectiveness Analysis in Acute Stroke Care

4/13/2017
Theresa Hoeft, University of Washington
Costs when task-sharing depression care between clinic and community partners

4/20/2017
Marcia Weaver, University of Washington
Health care utilization: a meta analyses of outpatient visits and inpatient admissions by age, gender for 188 countries from 1990-2015

4/27/2017
Solomon Lubinga, University of Washington
Preferences for voluntary medical male circumcision services for HIV prevention: a discrete choice experiment among fisherfolk in central Uganda

5/04/2017
Javay Grooms,University of Washington
State prevention interventions and opioid abuse

5/11/2017
Seyed Karimi, University of Washington, Tacoma
Pre-Birth Exposure to Ramadan, Height, and the Length of Gestation

5/18/2017
Sungchul Park, University of Washington
Theoretical and Empirical Analysis of Medicare Managed Care’s Response to Risk Adjustment

6/01/2017
Tricia Rodriguez, University of Washington
Minimizing Barriers to Retention on HIV Antiretroviral Therapy (ART): Results of Haiti’s “Multi-Month Scripting” (MMS) Initiative Extendin Prescribing Intervals for ART Patients

10/4/2017
Alice Ellyson
Pharmaceutical pricing anticipating entry: the case for insulin

10/11/2017
Badri Narayanan G., McKinsey Global Institute and UW
R&D Expenditure, Productivity and Profitability: Evidence from Indian Pharmaceutical Industry

10/18/2017
Lisa Laine
Effects of a National Drug Monitoring Intervention on Prescription Drug Abuse

11/1/2017
Davene Wright
Financial incentives to promote engagement in family based childhood obesity treatment: development of a discrete choice experiment

11/8/2017
Paul Fishman
Measuring Physician Productivity for Efficient Management of Primary Care Panels

11/15/2017
Josh Carlson
A Pilot Study Integrating Value of Research Analyses into NCI Clinical Trials Cooperative Group Research Review and Prioritization

11/29/2017
Josh Liao
The Value Proposition of Bundled Payment: National and Local Perspectives

12/6/2017
Nina Joyce, Brown University
The Impact of Dementia Special Care Units on Quality of Care: An Instrumental Variables Approach

01/07/2016
Muxin Zhai, Department of Economics, University of Washington
The impact of maternal exposure to air pollution on infant health.

01/14/2016
Peter Zweifel, University of Zurich, Zurich
Willingness-to-Pay for a New Pharmaceutical: Is It Worth the Money? Whose Money?

01/21/2016
David Kim, Department of Health Services, University of Washington
New Metrics for Economic Evaluation in the Presence of Heterogeneity: Focusing on evaluating policy alternatives rather than treatment alternatives

01/28/2016
Brian Dillon, Evans School of Public Policy and Governance, University of Washington
Long-Term Consequences of Consumption Seasonality

02/04/2016
Amy Cizik, PORPP, University of Washington
A Markovian cost Utility Model for Soft Tissue Sarcoma

02/11/2016
Carol Levin1 and Suzanne Kerns2, 1Department of Global Health and 2Department of Psychiatry and Behavioral Sciences, University of Washington
Including implementation stages in evaluating the costs of mental health interventions: A case study of scaling up evidence based practices in Washington State

02/18/2016
Bianca Frogner, Department of Family Medicine, University of Washington
Does unrestricted direct access to physical therapy impact health spending?

02/25/2016
Anirban Basu, PORPP, University of Washington Estimating Price Elasticities from a Value-based Formulary Implementation

03/03/2016
Guido Cataife, IMPAQ International, LLC
How much health does a dollar buy? The effect of health care spending on age-adjusted mortality in the US

03/10/2016
Kai Yeung, PROPP, University of Washington
Assessing stakeholder experiences and attitudes regarding cures

4/06/2016
SPECIAL JOINT SEMINAR WITH PORPP
WEDNESDAY 12:00-1:00 in SOCC 303
Ankur Pandya, Harvard University
Statins, Value and Values

4/14/2016
Ben Ely, University of Washington, Department of Health Services
A policy evaluation of the CDC’s campaign: Get Smart about Antibiotics

4/21/2016
Sherry Willis, University of Washington, Department of Psychiatry and Behavioral Sciences
Seattle Longitudinal Study: Current Findings and Future Research Possibilities

5/05/2016
Erin Vernon, Seattle University, Economics Department
Is Ignorance Bliss? A Systematic Review of Economic Evaluations of Thrombophilia Screening prior to Combined Hormonal Contraceptive Use

5/12/2016
Carrie Bennette, University of Washington, PORPP
Evaluating pharmaceutical innovation in the expanding market for oral chemotherapy

5/19/2016
Souvik Banerjee,University of Washington, PORPP
Identifying endogenous treatment effects using latent factor models

5/26/2016
Carol Levin,University of Washington, Global Health
Improving the Efficiency in HIV and TB: Overview of the Global Health Cost Consortium

10/06/2016
John Dickerson, Kaiser Permanente, Center for Health Research
Use of dose-response in clinical trials: challenges and opportunities

10/13/2016
Anupam Jena, Havard University
Marathons and Mortality

10/20/2016
Melissa Rosen, University of Washington
Changing Medicare Part D Presription Drug Plans: Estimating the Effects of Plan Switching on under-65 Dual Eligible

11/10/2016
Edwin Wong , University of Washington and VA Affairs
Massachusetts Health Reform and Dual Use of VA and non-VA Outpatient Services

11/17/2016
Ben Ely,University of Washington
Evaluation of CDC’s Get Smart Program on Appropriate Antibiotics Use

12/01/2016
Tiffany Radcliff, Texas A&M University
Price Searching in the Health Insurance Exchange

12/08/2016
Melissa Knox, University of Washington
Moral Hazard and Universal Health Care

01/14/2015
Scott Emerson, University of Washington
Methods Topic: Clinical trials Bayesian and Frequentist Inference Following Adaptive Trial Design

01/21/2015
Susan Shortreed,Group Health Research Institute
Methods Topic: Dynamic Treatments Constructing Optimal Dynamic Antipsychotic Treatment Regimes for Patients with Schizophrenia

01/28/2015
Abraham Flaxman, Institute for Health Metrics and Evaluation
Methods Topic: Meta-Regression The Integrative Meta-regression Framework from the Global Burden of Disease (DisMod-MR)

02/04/2015
Ruth Etzioni,Fred Hutchinson Cancer Research Center
Methods Topic: Simulation ModelingSimulation modeling as a tool for comparative effectiveness: an overview illustrated by examples from cancer research

02/10/2015
Mark Sculpher, University of York, UK
Health Sciences Turner Auditorium, D-209 Is NICE doing more harm than good to population health?

02/11/2015
Ali Shojaie, University of Washington
Methods Topic: Machine Learning How reliable are our models in high dimensions?

02/18/2015
Carrie Bennette, University of Washington
Methods Topic: Value of Information Minimal Modeling Value of Information Analyses for Prioritization Decisions within a Cancer Clinical Trials Cooperative Group

02/25/2015
Holly Janes, Fred Hutchinson Cancer Research Center
Methods Topic: Treatment Effect Heterogeneity (Biomarker Evaluation) An overview of current methodology for designing and analyzing clinical trials evaluating biomarkers for predicting treatment effect

03/04/2014
Donald Hedeker,University of Chicago, IL
Methods Topic: Intensive Longitudinal DataModeling between and within-subject variances using mixed effects location scale models for intensive longitudinal data

03/11/2015
Anirban Basu, University of Washington
Methods Topic: Instrumental Variables and Heterogeneity Understanding identification in instrumental variables methods and its application in comparative effectiveness research

04/08/2015
Sarah Beth Barnett, University of Washington
Massachusetts health reform: financial and mental health effects

04/15/2015
Pierre Thomas Lé, HEC Monteal, Canada
Physician Practice Style and Healthcare Costs: Evidence from Emergency Departments

04/22/2015
Bianca Frogner, University of Washington
Health Care Workforce Trends

04/29/2015
Kai Yeung,University of Washington
Application of Cost-Effectiveness Logic to US Managed Care Drug Formularies: Long term Outcomes of a Value-based Formulary

05/06/2015
Zachary Marcum, University of Washington
Medicare Part D: A Tale of Two Analyses

05/13/2015
Tamara Konetzka, University of Chicago, IL
Effects of Malpractice Litigation on Nursing Home Ownership Change and Exit

05/20/2014
Benjamin Ely,University of Washington
Acute bronchitis and patterns of antibiotic use

05/27/2015
Anirban Basu, University of Washington
2SLS vs 2SRI: Appropriate methods for rare outcomes and/or rare exposures

10/01/2015
Souvik Banerjee, University of Washington
An Analysis of the Effect of Psychiatric Disorders on Probation Outcomes and Prison Entry among Probationers in New York State

10/08/2015
Ruth Etzioni, University of Washington and Fred Hutch
Limitations of Screening Trials in Developing Cancer Screening Policies

10/15/2015
Anirban Basu and Norma Coe, University of Washington
Potential R01s: Where can we collaborate?

10/22/2015
Amy Cizik, University of Washington
Variations in Surgeon Treatment Preferences for Soft Tissue Sarcoma: Chronic vs. Temporary Health State Utility Calculations

10/29/2015
Norma Coe,University of Washington
Assisted Living Communities’ Impact on Nursing Homes

11/05/2015
Bianca Frogner, University of Washington
Low-wage and Low-skilled Health Care Workers

11/12/2015
Davene Wright, University of Washington and Seattle Children’s
Hardwired for Hope: Measuring Parental Optimism Bias around Childhood Obesity-Related Outcomes

11/19/2015
Carrie Bennett,University of Washington
Evaluating trends in cancer drug prices

12/03/2015
Joan Teno, University of Washington
Post acute care and Health Care Reform: Wild, Wild, Wet

1/9/2014
Marcia Weaver, Department of Global Health, University of Washington
Integrated infectious disease training and on-site support in Uganda: Design and preliminary results for a cost-effectiveness analysis

1/16/2014
Stephane Verguet, Department of Global Health, University of Washington
Universal health coverage & efficient provision of financial risk protection

1/23/2014
Lin-Chi Hsu, Department of Economics, University of Washington
The Timing of Welfare Payments and Domestic Violence

2/6/2014
Carol Levin, Department of Global Health, University of Washington
A new Global Investment Framework for Women’s and Children’s Health

2/20/2014
Nathan Tefft, Department of Health Services, University of Washington
Financial Conflicts of Interest in Medicine

2/27/2014
Anupam Jena, Department of Health Care Policy, Harvard Medical School
Mortality among patients hospitalized with acute cardiovascular conditions during dates of national cardiology meetings

3/6/2014
Sarah Taubman, Department of Health Services, University of Washington
Recent results from the Oregon Health Insurance Experiment: Emergency department use and labor market activity

3/13/2014
Samuel Henly, Department of Economics, University of Washington
Sex Workers, Job Lock, and the Affordable Care Act

4/10/2014
Rosa Avila, Department of Health Services, University of Washington
The Massachusetts Health Reform and Children’s Health: Can We Achieve Health and Health Care Equity among All Children?

4/24/2014
Zachary Olson and John Staples, Department of Global Health, University of Washington
Helmet Regulation in Vietnam: An Extended Cost-Effectiveness Analysis

5/1/2014
John Dickerson, Department of Health Services, University of Washington
Medication Adherence through Industry-Level Business Cycles: an Application of the Economic Stress Hypothesis

5/8/2014
Joshua Roth, Fred Hutchinson Cancer Research Center
Economic Return from the Women’s Health Initiative Estrogen plus Progestin Clinical Trial

5/15/2014
Steven Zeliadt, Department of Health Services, University of Washington
Translating lung cancer screening from the trial setting into clinical practice at VA

5/22/2014
Justin Robertson, Department of Economics, University of Washington
Are Physicians Learning? Using Person-Centered Treatment Effects to Evaluate Learning Among Medicaid Patients with Schizophrenia

5/29/2014
Andrew J. Brunskill, Departments of Epidemiology and Health Services, University of Washington
What is different about smoking in pregnancy : Psychology, physiology and economics

6/5/2014
Norma Coe, Department of Health Services, University of Washington
Is There Intra-Family Moral Hazard in Long-Term Care?

10/1/2014

Davene R. Wright, Seattle Children’s Research Institute
Improving parental engagement in obesity interventions through risk communication

10/8/2014
Edwin S. Wong,VA Puget Sound Health Care System

10/15/2014
David D. Kim,Department of Health Services
Long term cost-effectiveness of alcohol-use disorder; PDP review

10/22/2014
Justin Robertson,Department of Health Services
Optimal Insurance Contracts with Patients and Payment Contracts with Medical Providers when Threat of Waiving Copayments Exists

10/29/2014
Souvik Banerjee, Pharmaceutical Outcomes Research and Policy Program

1/10/2013
Steve Zeliadt, University of Washington
Potential Pathways for Containing Costs of Lung Cancer Screening for VHA

1/17/2013
Benjamin Hansen, University of Oregon
Medical Marijuana Laws and Teen Drug Use

1/31/2013
Joe Dieleman, University of Washington
Measuring the displacement and replacement of development assistance for health

2/7/2013
Nathan Tefft, University of Washington
The Dow is Killing Me: Risky Health Behaviors and the Stock Market

2/21/2013
Davene Wright, University of Washington
The Cost-Effectiveness of Screening U.S. Adolescents for Eating Disorders

2/28/2013
Shamma Alam, University of Washington
How Does Parental Illness Affect Children? Impact of Parental Health Shocks on Child Labor and Education in Tanzania

3/7/2013
Norma Coe, University of Washington
Disability and Labor Supply: The Role of Health Insurance

3/14/2013
Anirban Basu, University of Washington
Long-Term Health Returns to Quality of Schooling: the Roles of Selection and Heterogeneity

4/4/2013
Ruth Etzioni, University of Washington
Measuring Overdiagnosis in Breast and Prostate Cancer Screening: Overcoming Challenges, Avoiding Mistakes

4/11/2013
Fahad Khalil, University of Washington
Contracts offered by Bureaucrats

4/18/2013
Charles Manski, Northwestern University
Two Problems in Medical Decision Making under Ambiguity

4/25/2013
Carol Levin, University of Washington
Using cost analysis to better design global health interventions: Lessons from HPV vaccination in Peru, Uganda, India and Vietnam

5/2/2013
Christopher Auld, University of Victoria
Minimum pricing of alcohol: Theory and evidence

5/9/2013
Julia Slejko, University of Washington
Using Latent Class Probability Estimation and Residual Inclusion to Address Confounding in Medication Adherence Modeling

5/16/2013
Amitabh Chandra, Harvard University
Technology Growth and Expenditure Growth in Health Care

5/23/2013
Mark Long, University of Washington
An Altruism Adjusted Measure of the Value of a Statistical Life

5/30/2013
Sarah Taubman, University of Washington
The Oregon Health Insurance Experiment: Evidence from the First Two Years

9/26/2013
Michael Hanlon, Institute for Health Metrics and Evaluation, University of Washington
Development Assistance for Health: Its allocation and impact on population health

10/10/2013
Shamma Alam, Department of Economics, University of Washington
Parental Health Shocks, Child Labor and Educational Outcomes: Evidence from Tanzania

10/17/2013
Sarit Weisburd, Departments of Economics, The Hebrew University & University of Washington
Does Police Presence Reduce Car Accidents?

10/24/2013
Kathleen Mullen, RAND Corporation
Disability Insurance and Healthcare Reform: Evidence from Massachusetts

11/7/2013
Joseph Dieleman, Institute for Health Metrics and Evaluation, University of Washington
A combination of effects: how economic development, development assistance, democratization and government health spending affect under-five mortality

11/14/2013
Norma Coe, Department of Health Services, University of Washington
Overcoming Barriers to Life Insurance Coverage: A Behavioral Approach

12/5/2013
Arati Dahal, Department of Health Services, University of Washington
The Role of Health on Giving

10/4/2012
Damian Walker, Bill and Melinda Gates Foundation (flyer)
The Portfolio Management Pilot: Developing a standard methodology for determining the potential risk and return of products in the Bill & Melinda Gates Foundation Global Health’s investment portfolio

10/11/2012
Robert Penfold, Group Health Research Institute
Cumulative Total Charges for Care Among Breast, Colorectal, and Lung Cancer Patients in the Oncology Nurse Navigator Trial

10/18/2012
Rachel Nugent, University of Washington
How Does Chronic Disease Control Stack Up Among Economics Nobel Laureates?
Value of Information Experiment Results

10/24/2012*
Andy Willan, University of Toronto   (*Joint with CHASE WIP – special Wed. session)
Value and Uncertainty in the Pricing New Health Care Interventions (details)

11/1/2012
Sean Sullivan, University of Washington
Financial Risk-Sharing Agreements as a Mechanism for Market Access to Health Technology in Low to Middle Income Countries

11/8/2012
Joelle Abramowitz, University of Washington
Assisted Reproductive Technology and Women’s Marriage and Birth Timing: Survival and Competing Risks Analyses.

11/15/2012
Doug Conrad, University of Washington

11/29/2012
Santosh Kumar, Institute for Health Metrics and Evaluation
Geographic constraint to institutional delivery in rural India: An instrumental variable approach

12/6/2012
David Meltzer, University of Chicago
Redesign of Care for Patients at High Risk of Hospitalization in a Reforming U.S. Healthcare System: Rationale for a CMMI Innovation Challenge Project